Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Psychotic Disorders
•
Psychopharmacology
How do you approach deprescribing anticholinergics in patients with psychotic disorders?
Related Questions
How will the removal of the clozapine REMS requirement change your clinical practice?
How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?
How do you monitor patients who are symptomatically well-managed on clozapine with supratherapeutic drug levels?
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
How do you use lithium levels to adjust treatment during mania?
What pharmacologic treatments have you found helpful in treating comorbid schizophrenia and OCD?
How do you view the risk of tardive dysinesia and other side effects in your female patients with treatment-resistant depression who are stable on an atypical antipsychotic?
When do you recommend HLA testing prior to prescribing lamotrigine, carbamazepine, or oxcarbazepine to patients of Asian descent?
Do you routinely prescribe an anticholinergic agent for EPS prophylaxis when starting or continuing antipsychotics or do you prefer to use it only as needed (PRN) if/when symptoms develop?
How do you manage withdrawal symptoms of SNRIs that exist even after slow taper?